Texas A&M Health Science College of Medicine, Institute for Regenerative Medicine at Scott & White, Temple, TX 76502, USA.
Cytotherapy. 2010 Sep;12(5):576-8. doi: 10.3109/14653249.2010.507330.
Abstract We address the issue of the potential for malignant transformation of cultured mesenchymal stromal cells (MSC) commonly used in clinical cell-therapy protocols and describe the culture conditions under which tumorigenesis is likely to be an extremely uncommon event.
摘要 我们探讨了临床细胞治疗方案中常用的培养间充质基质细胞(MSC)发生恶性转化的可能性,并描述了可能极不可能发生致瘤的培养条件。